Keywords: Doxil, Johnson & Johnson, Sun Pharma, Generic, USA, FDA, Drug shortage, Lipodox

FDA approval of generic cancer drug Doxil is expected to help resolve shortage

Article | 06 February 2013

Print This

The US Food and Drug Administration has approved the first generic version of the cancer drug Doxil (doxorubicin hydrochloride liposome ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in